2036 related articles for article (PubMed ID: 32458193)
21. Neurological manifestations of SARS-CoV-2: complexity, mechanism and associated disorders.
Tyagi K; Rai P; Gautam A; Kaur H; Kapoor S; Suttee A; Jaiswal PK; Sharma A; Singh G; Barnwal RP
Eur J Med Res; 2023 Aug; 28(1):307. PubMed ID: 37649125
[TBL] [Abstract][Full Text] [Related]
22. Neurological manifestations of COVID-19: a review of what we know so far.
Gklinos P
J Neurol; 2020 Sep; 267(9):2485-2489. PubMed ID: 32458197
[TBL] [Abstract][Full Text] [Related]
23. SARS-CoV-2, More than a Respiratory Virus: Its Potential Role in Neuropathogenesis.
Singal CMS; Jaiswal P; Seth P
ACS Chem Neurosci; 2020 Jul; 11(13):1887-1899. PubMed ID: 32491829
[TBL] [Abstract][Full Text] [Related]
24. Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review.
Zubair AS; McAlpine LS; Gardin T; Farhadian S; Kuruvilla DE; Spudich S
JAMA Neurol; 2020 Aug; 77(8):1018-1027. PubMed ID: 32469387
[TBL] [Abstract][Full Text] [Related]
25. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19).
Harapan BN; Yoo HJ
J Neurol; 2021 Sep; 268(9):3059-3071. PubMed ID: 33486564
[TBL] [Abstract][Full Text] [Related]
26. Neurological manifestations and complications of COVID-19: A literature review.
Ahmad I; Rathore FA
J Clin Neurosci; 2020 Jul; 77():8-12. PubMed ID: 32409215
[TBL] [Abstract][Full Text] [Related]
27. Neurobiology of COVID-19.
Fotuhi M; Mian A; Meysami S; Raji CA
J Alzheimers Dis; 2020; 76(1):3-19. PubMed ID: 32538857
[TBL] [Abstract][Full Text] [Related]
28. Neuropathogenesis of SARS-CoV-2 infection.
Khan S; Gomes J
Elife; 2020 Jul; 9():. PubMed ID: 32729463
[TBL] [Abstract][Full Text] [Related]
29. Neurological manifestations of COVID-19.
Kanwar D; Baig AM; Wasay M
J Pak Med Assoc; 2020 May; 70(Suppl 3)(5):S101-S103. PubMed ID: 32515379
[TBL] [Abstract][Full Text] [Related]
30. Neurological manifestations in coronavirus disease 2019.
Corona T; Rodríguez-Violante M; Delgado-García G
Gac Med Mex; 2020; 156(4):317-320. PubMed ID: 32831319
[TBL] [Abstract][Full Text] [Related]
31. Involvement of the Nervous System in SARS-CoV-2 Infection.
Li H; Xue Q; Xu X
Neurotox Res; 2020 Jun; 38(1):1-7. PubMed ID: 32399719
[TBL] [Abstract][Full Text] [Related]
32. Potential neurological impact of coronaviruses: implications for the novel SARS-CoV-2.
Iroegbu JD; Ifenatuoha CW; Ijomone OM
Neurol Sci; 2020 Jun; 41(6):1329-1337. PubMed ID: 32424503
[TBL] [Abstract][Full Text] [Related]
33. Temporal Correlation Between Neurological and Gastrointestinal Symptoms of SARS-CoV-2.
Bostancıklıoğlu M
Inflamm Bowel Dis; 2020 Jul; 26(8):e89-e91. PubMed ID: 32440692
[TBL] [Abstract][Full Text] [Related]
34. COVID-19 and Neurology: An Emerging Association.
Gupta A; Yadav P; Kumar D
Infect Disord Drug Targets; 2021; 21(8):e160921191570. PubMed ID: 33602080
[TBL] [Abstract][Full Text] [Related]
35. Neurological manifestations of coronavirus infections - a systematic review.
Almqvist J; Granberg T; Tzortzakakis A; Klironomos S; Kollia E; Öhberg C; Martin R; Piehl F; Ouellette R; Ineichen BV
Ann Clin Transl Neurol; 2020 Oct; 7(10):2057-2071. PubMed ID: 32853453
[TBL] [Abstract][Full Text] [Related]
36. Current evidence of neurological features, diagnosis, and neuropathogenesis associated with COVID-19.
Puccioni-Sohler M; Poton AR; Franklin M; Silva SJD; Brindeiro R; Tanuri A
Rev Soc Bras Med Trop; 2020; 53():e20200477. PubMed ID: 33027418
[TBL] [Abstract][Full Text] [Related]
37. Vascular Endothelial Growth Factor (VEGF) as a Vital Target for Brain Inflammation during the COVID-19 Outbreak.
Yin XX; Zheng XR; Peng W; Wu ML; Mao XY
ACS Chem Neurosci; 2020 Jun; 11(12):1704-1705. PubMed ID: 32485101
[TBL] [Abstract][Full Text] [Related]
38. Possible mechanism of central nervous system targeting and neurological symptoms of the new-coronavirus (COVID-19): literature review.
Jumagaliyeva M; Ayaganov D; Saparbayev S; Tuychibaeva N; Abdelazim IA; Kurmambayev Y; Khamidullina Z; Yessenamanova S
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(19):9420-9428. PubMed ID: 37843354
[TBL] [Abstract][Full Text] [Related]
39. COVID-19: is there a link between the course of infection and pharmacological agents in diabetes?
Filardi T; Morano S
J Endocrinol Invest; 2020 Aug; 43(8):1053-1060. PubMed ID: 32495299
[TBL] [Abstract][Full Text] [Related]
40. Central Nervous System Manifestations Associated with COVID-19.
Divani AA; Andalib S; Biller J; Di Napoli M; Moghimi N; Rubinos CA; Nobleza CO; Sylaja PN; Toledano M; Lattanzi S; McCullough LD; Cruz-Flores S; Torbey M; Azarpazhooh MR
Curr Neurol Neurosci Rep; 2020 Oct; 20(12):60. PubMed ID: 33128130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
